Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
SZSE:300760.SZ
256.8 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| 11,739.967 | 11,582.226 | 9,610.717 | 8,004.046 | 6,659.603 | 4,684.817 | 3,725.742 | 2,601.191 | 1,612.185 | 940.505 | 1,359.671 |
| Depreciation & Amortization
| 1,468.526 | 1,039.173 | 885.057 | 700.408 | 472.12 | 394.307 | 331.417 | 297.682 | 284.01 | 315.59 | 210.922 |
| Deferred Income Tax
| 0 | -642.409 | -174.941 | 59.885 | -53.627 | -49.157 | -146.661 | 0 | 1.074 | 210.647 | 0 |
| Stock Based Compensation
| 0 | 217.776 | 308.006 | 0 | 0 | 0 | 0 | 0 | 133.976 | 204.255 | 117.914 |
| Change In Working Capital
| -1,167.224 | -1,397.665 | 1,348.606 | 387.899 | 1,322.035 | -514.563 | 31.243 | 36.832 | 1,006.311 | 392.015 | 0 |
| Accounts Receivables
| -347.147 | -680.906 | -1,047.004 | -153.442 | -3.271 | -312.252 | -247.772 | -516.657 | 0 | 0 | 0 |
| Inventory
| -782.047 | -201.432 | -523.005 | -133.631 | -1,448.061 | -706.745 | -224.044 | -625.883 | -208.625 | -177.601 | 0 |
| Accounts Payables
| 0 | -769.194 | 3,093.557 | 615.088 | 2,826.994 | 553.591 | 649.72 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -38.03 | 253.868 | -174.941 | 59.885 | -53.627 | -49.157 | 255.287 | 662.714 | 1,214.936 | 569.617 | 0 |
| Other Non Cash Items
| 390.772 | 262.925 | 163.704 | -93.704 | 416.351 | 157.233 | -53.817 | 364.662 | 1.971 | -39.109 | -1,359.671 |
| Operating Cash Flow
| 12,432.041 | 11,062.025 | 12,141.148 | 8,998.649 | 8,870.11 | 4,721.795 | 4,034.585 | 3,300.367 | 3,039.526 | 2,023.903 | 1,741.479 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -1,959.448 | -2,688.668 | -1,915.528 | -1,402.494 | -1,182.711 | -776.861 | -678.277 | -466.73 | -413.536 | -595.41 | -588.439 |
| Acquisitions Net
| -5,773.292 | -802.334 | 71.487 | -3,519.677 | -26.761 | -12.439 | -70.074 | 1.344 | -646.854 | -103.938 | -72.253 |
| Purchases Of Investments
| -1,112.302 | -1,311.586 | -36.5 | -51.681 | -20 | -5 | -112.651 | -2,160.57 | -15,089.58 | -11,634.04 | -7,091.32 |
| Sales Maturities Of Investments
| 1,329.272 | 0.329 | -71.487 | 51.681 | 26.761 | 12.439 | 0 | 2,723.069 | 17,171.755 | 14,335.297 | 7,502.029 |
| Other Investing Activites
| 132.559 | 4,109.327 | -1,267.742 | 110.053 | -3,988.422 | 3.895 | -14.343 | -84.03 | 38.329 | 5.544 | 5.208 |
| Investing Cash Flow
| -7,383.211 | -692.932 | -3,219.771 | -4,812.118 | -5,191.133 | -777.966 | -692.62 | 13.084 | 1,060.114 | 2,007.453 | -244.776 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -2.857 | -18.766 | 0 | -440.732 | 0 | 0 | 0 | -1,684.438 | 1,541.434 | 234.898 | -1,316.777 |
| Common Stock Issued
| 0 | 0 | 152.433 | 999.991 | 0 | -9.333 | -15.294 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -6.075 | -999.944 | -999.991 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -8,742.502 | -10,669.617 | -4,232.875 | -3,039.228 | -1,823.537 | -1,215.691 | -949.229 | -611.317 | -6,518.176 | -3,425.431 | -45.453 |
| Other Financing Activities
| -136.355 | -81.228 | -113.892 | -1,124.91 | -29.589 | -25.88 | 3,841.347 | -156.771 | 3,183.882 | -689.622 | -788.704 |
| Financing Cash Flow
| -8,881.713 | -10,775.686 | -5,194.278 | -4,604.87 | -1,853.126 | -1,241.571 | 2,892.118 | -2,452.526 | -1,792.86 | -3,880.154 | -2,150.933 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 72.189 | 101.367 | 113.816 | -171.446 | -197.471 | 23.651 | 184.143 | -155.88 | 132.893 | 41.166 | -11.539 |
| Net Change In Cash
| -3,760.693 | -305.225 | 3,840.915 | -589.785 | 1,628.38 | 2,725.909 | 6,418.227 | 705.045 | 2,439.673 | 192.367 | -665.769 |
| Cash At End Of Period
| 14,907.726 | 18,668.419 | 18,973.644 | 15,132.729 | 15,722.513 | 14,094.134 | 11,368.224 | 4,949.997 | 4,244.952 | 1,805.279 | 1,612.912 |